Steatohepatitis: A tale of two “hits”?

Cited by (136)

Items 101–136 of 136

1. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis
   Nishio, Takahiro, Taura, Kojiro, Iwaisako, Keiko, Koyama, Yukinori, Tanabe, Kazutaka, Yamamoto, Gen, Okuda, Yukihiro, Ikeno, Yoshinobu, Yoshino, Kenji, Kasai, Yosuke et al. · 2017 · Journal of Gastroenterology
2. Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis
   Montfort, Claudia von, Matias, Núria, Fernandez, Anna, Fucho, Raquel, de la Rosa, Laura Conde, Martinez-Chantar, Maria Luz, Mato, José M., Machida, Keigo, Tsukamoto, Hidekazu, Murphy, Michael P. et al. · 2012 · Journal of Hepatology
3. A complex role of activin A in non-alcoholic fatty liver disease
   Yndestad, Arne, Haukeland, John Willy, Dahl, Tuva Børresdatter, Bjøro, Kristian, Gladhaug, Ivar Prydz, Berge, Christ, Damås, Jan Kristian, Haaland, Terese, Løberg, Else Marit, Linnestad, Paul et al. · 2009 · The American Journal of Gastroenterology
4. Glucose fluctuation increased hepatocyte apoptosis under lipotoxicity and the involvement of mitochondrial permeability transition opening
   Yin, Xueyao, Zheng, Fenping, Pan, Qianqian, Zhang, Saifei, Yu, Dan, Xu, Zhiye, Li, Hong · 2015 · Journal of Molecular Endocrinology
5. Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH
   Svegliati-Baroni, Gianluca, Patrício, Bárbara, Lioci, Gessica, Macedo, Maria Paula, Gastaldelli, Amalia · 2020 · International Journal of Molecular Sciences
6. Macrophages in nonalcoholic fatty liver disease: a role model of pathogenic immunometabolism
   Krenkel, Oliver, Tacke, Frank · 2017 · Seminars in Liver Disease
7. ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK/mTOR mediated autophagy
   Lu, Wanpeng, Mei, Jinyu, Yang, Juan, Wu, Zhihan, Liu, Jiayuan, Miao, Pengyu, Chen, Yiliang, Wen, Zhenfan, Zhao, Zhongting, Kong, Hua et al. · 2020 · Life Sciences
8. The hepatic “matrisome” responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice
   Massey, Veronica L., Dolin, Christine E., Poole, Lauren G., Hudson, Shanice V., Siow, Deanna L., Brock, Guy N., Merchant, Michael L., Wilkey, Daniel W., Arteel, Gavin E. · 2017 · Hepatology
9. Association among serum ferritin, alanine aminotransferase levels, and metabolic syndrome in Korean postmenopausal women
   Choi, K.M., Lee, K.W., Kim, H.Y., Seo, J.A., Kim, S.G., Kim, N.H., Choi, D.S., Baik, S.H. · 2005 · Metabolism
10. The Origin and Fate of Liver Myofibroblasts
    Kim, Hyun Young, Sakane, Sadatsugu, Eguileor, Alvaro, Carvalho Gontijo Weber, Raquel, Lee, Wonseok, Liu, Xiao, Lam, Kevin, Ishizuka, Kei, Rosenthal, Sara Brin, Diggle, Karin et al. · 2024 · Cellular and Molecular Gastroenterology and Hepatology
11. Leptin in hepatocellular carcinoma
    Wang, Shen-Nien · 2010 · World Journal of Gastroenterology
12. Lipoprotein Lipase Up‐regulation in Hepatic Stellate Cells Exacerbates Liver Fibrosis in Nonalcoholic Steatohepatitis in Mice
    Teratani, Toshiaki, Tomita, Kengo, Furuhashi, Hirotaka, Sugihara, Nao, Higashiyama, Masaaki, Nishikawa, Makoto, Irie, Rie, Takajo, Takeshi, Wada, Akinori, Horiuchi, Kazuki et al. · 2019 · Hepatology Communications
13. A role for metabolism in Rett syndrome pathogenesis: New clinical findings and potential treatment targets
    Justice, Monica J, Buchovecky, Christie M, Kyle, Stephanie M, Djukic, Aleksandra · 2013 · Rare Diseases
14. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease
    Lê, Kim-Anne, Bortolotti, Murielle · 2008 · Current Opinion in Clinical Nutrition and Metabolic Care
15. B Cell-Activating Factor is Associated With the Histological Severity of Nonalcoholic Fatty Liver Disease
    Miyake, Teruki, Abe, Masanori, Tokumoto, Yoshio, Hirooka, Masashi, Furukawa, Shinya, Kumagi, Teru, Hamada, Maho, Kawasaki, Keitarou, Tada, Fujimasa, Ueda, Teruhisa et al. · 2013 · Hepatology International
16. Carbon tetrachloride (CCl4) accelerated development of non-alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF)
    Zhang, Guodong, Wang, Xiaoli, Chung, Tzu-Yang, Ye, Weiwei, Hodge, Lauren, Zhang, Likun, Chng, Keefe, Xiao, Yong-Fu, Wang, Yixin Jim · 2020 · BMC Gastroenterology
17. DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model
    Achiwa, Koichi, Ishigami, Masatoshi, Ishizu, Yoji, Kuzuya, Teiji, Honda, Takashi, Hayashi, Kazuhiko, Hirooka, Yoshiki, Katano, Yoshiaki, Goto, Hidemi · 2016 · Biochemical and Biophysical Research Communications
18. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis
    Schumacher, J.D., Kong, B., Pan, Y., Zhan, L., Sun, R., Aa, J., Rizzolo, D., Richardson, J.R., Chen, A., Goedken, M. et al. · 2017 · Toxicology and Applied Pharmacology
19. Insulin Regulation of Hepatic Lipid Homeostasis
    Uehara, Kahealani, Santoleri, Dominic, Whitlock, Anna E. Garcia, Titchenell, Paul M. · 2023 · Comprehensive Physiology
20. GLP‐1 receptor agonists: effects on the progression of non‐alcoholic fatty liver disease
    Liu, Jia, Wang, Guang, Jia, Yumei, Xu, Yuan · 2015 · Diabetes/Metabolism Research and Reviews
21. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH
    Hernandez, Gabriella V., Smith, Victoria A., Melnyk, Megan, Burd, Matthew A., Sprayberry, Kimberly A., Edwards, Mark S., Peterson, Daniel G., Bennet, Darin C., Fanter, Rob K., Columbus, Daniel A. et al. · 2020 · American Journal of Physiology-Gastrointestinal and Liver Physiology
22. Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway
    Lu, Zengsheng, He, Beihui, Chen, Zhiyun, Yan, Maoxiang, Wu, Liyan · 2020 · BMC Immunology
23. Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice
    Du, Meng, Wang, Xiaojing, Yuan, Lin, Liu, Bing, Mao, Xiaoxiang, Huang, Dandan, Yang, Liu, Huang, Kun, Zhang, Fengxiao, Wang, Yan et al. · 2020 · Journal of Hepatology
24. Non-alcoholic fatty liver disease: pathogenesis and models
    Zhong, Hanxiang · 2024 · American Journal of Translational Research
25. Interaction mechanisms between major depressive disorder and non-alcoholic fatty liver disease
    Shao, Qi, Wu, Yiping, Ji, Jing, Xu, Tian, Yu, Qiaoyu, Ma, Chongyang, Liao, Xuejing, Cheng, Fafeng, Wang, Xueqian · 2021 · Frontiers in Psychiatry
26. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats
    Yao, Xiaorui, Xia, Fan, Tang, Waijiao, Xiao, Chunxin, Yang, Miaoting, Zhou, Benjie · 2018 · Journal of Ethnopharmacology
27. Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease
    Chen, Xu, Sun, Xiaoyuan, Shen, Tianran, Chen, Qian, Chen, Shen, Pang, Juan, Mi, Jiaxin, Tang, Yi, You, Yiran, Xu, Huihui et al. · 2020 · Free Radical Biology and Medicine
28. Dihydromyricetin attenuates palmitic acid-induced oxidative stress by promoting autophagy via SIRT3-ATG4B signaling in hepatocytes
    Huang, Li, Zeng, Xianglong, Li, Bo, Wang, Cong, Zhou, Min, Lang, Hedong, Yi, Long, Mi, Mantian · 2021 · Nutrition & Metabolism
29. Role of Ca²⁺ channels in non-alcoholic fatty liver disease and their implications for therapeutic strategies (Review)
    Chen, Xingyue, Zhang, Li, Zheng, Liming, Tuo, Biguang · 2022 · International Journal of Molecular Medicine
30. Advancements in MAFLD Modeling with Human Cell and Organoid Models
    Wang, Shi-Xiang, Yan, Ji-Song, Chan, Yun-Shen · 2022 · International Journal of Molecular Sciences
31. ZBP1 promotes hepatocyte pyroptosis in acute liver injury by regulating the PGAM5/ROS pathway
    Yan, Shengguang, Yu, Lina, Chen, Ziren, Xie, Dan, Huang, Zuli, Ouyang, Shi · 2024 · Annals of Hepatology
32. Bazedoxifene and conjugated estrogen combination maintains metabolic homeostasis and benefits liver health
    Chen, Karen Lee Ann, Zhao, Yiru Chen, Hieronymi, Kadriye, Smith, Brandi Patricia, Madak-Erdogan, Zeynep · 2017 · PLOS ONE
33. Serum osteocalcin levels in children with nonalcoholic fatty liver disease
    Amin, Saleh, El Amrousy, Doaa, Elrifaey, Shaymaa, Gamal, Rasha, Hodeib, Hossam · 2018 · Journal of Pediatric Gastroenterology and Nutrition
34. Increased oxidative stress and toxicity in ADH and CYP2E1 overexpressing human hepatoma VL-17A cells exposed to high glucose
    Chandrasekaran, Karthikeyan, Swaminathan, Kavitha, Kumar, S. Mathan, Clemens, Dahn L., Dey, Aparajita · 2012 · Integrative Biology
35. Liver-specific knockout of B cell lymphoma 6 suppresses progression of non-alcoholic steatohepatitis in mice
    Chikada, Hiromi, Ida, Kinuyo, Nishikawa, Yuji, Inagaki, Yutaka, Kamiya, Akihide · 2020 · Scientific Reports
36. Intervention by picroside II on FFAs induced lipid accumulation and lipotoxicity in HepG2 cells
    Dhami-Shah, Hiteshi, Vaidya, Rama, Talwadekar, Manasi, Shaw, Eisha, Udipi, Shobha, Kolthur-Seetharam, Ullas, Vaidya, Ashok D.B. · 2021 · Journal of Ayurveda and Integrative Medicine